Dean J Naisbitt Selected Research

4-phenylenediamine (p-phenylenediamine)

10/2015	In Vitro Priming of Naı̈ve T-cells with p-Phenylenediamine and Bandrowski's Base.
8/2014	The importance of hapten-protein complex formation in the development of drug allergy.
3/2010	Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein.
6/2009	A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine.
3/2009	Investigation of the immunogenicity of p-phenylenediamine and Bandrowski's base in the mouse.
4/2008	Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski's base.
2/2007	Activation of human dendritic cells by p-phenylenediamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dean J Naisbitt Research Topics

Disease

43	Hypersensitivity (Allergy) 01/2022 - 09/2002
14	Drug Hypersensitivity (Drug Allergy) 01/2022 - 01/2004
10	Chemical and Drug Induced Liver Injury 01/2021 - 09/2005
8	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2007
6	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 06/2010
6	Allergic Contact Dermatitis 10/2015 - 02/2007
5	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2021 - 03/2011
4	Iatrogenic Disease 01/2021 - 02/2013
3	Exanthema (Rash) 01/2021 - 06/2003
2	Infections 01/2022 - 01/2021
2	Cicatrix (Scar) 01/2022 - 01/2021
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021 - 11/2020
2	Drug Hypersensitivity Syndrome 01/2021 - 01/2021
2	Skin Diseases (Skin Disease) 01/2020 - 01/2004
2	Liver Failure 11/2016 - 01/2016
2	Contact Dermatitis (Eczema, Contact) 03/2010 - 03/2009
1	Gram-Positive Bacterial Infections 01/2022
1	COVID-19 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Eosinophilia 01/2021
1	Agranulocytosis (Granulocytopenia) 11/2020
1	Immediate Hypersensitivity 10/2020
1	Hepatitis C 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Meningism (Meningismus) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Neoplasms (Cancer) 04/2013
1	Autoimmune Diseases (Autoimmune Disease) 04/2013

Drug/Important Bio-Agent (IBA)

35	Pharmaceutical PreparationsIBA 01/2022 - 06/2003
12	AntigensIBA 10/2020 - 09/2002
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
11	Sulfamethoxazole FDA LinkGeneric 01/2021 - 09/2002
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2010
8	abacavir (Ziagen)FDA Link 01/2020 - 05/2003
7	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2013
7	4-phenylenediamine (p-phenylenediamine)FDA Link 10/2015 - 02/2007
6	HLA-B57 antigenIBA 01/2020 - 11/2012
6	LactamsIBA 01/2018 - 06/2012
6	Carbamazepine (Tegretol)FDA LinkGeneric 02/2017 - 07/2006
6	Tuberculin (PPD)IBA 10/2015 - 02/2007
5	HLA-B Antigens (HLA-B)IBA 01/2021 - 05/2007
5	Piperacillin FDA LinkGeneric 01/2018 - 07/2011
4	HaptensIBA 01/2021 - 09/2011
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 01/2004
3	Amoxicillin (Wymox)FDA LinkGeneric 11/2020 - 10/2016
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2020 - 10/2016
3	Floxacillin (Flucloxacillin)IBA 02/2017 - 02/2013
3	SulfonamidesIBA 08/2014 - 02/2010
2	GlycopeptidesIBA 01/2022 - 01/2021
2	lumacaftorIBA 01/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Vancomycin FDA LinkGeneric 01/2022 - 01/2021
2	Dapsone FDA Link 10/2021 - 01/2019
2	Tolvaptan FDA Link 01/2021 - 11/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2020
2	Penicillins (Penicillin)FDA Link 12/2017 - 09/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 01/2015
2	Hair DyesIBA 10/2015 - 02/2007
2	Bandrowski's baseIBA 10/2015 - 04/2008
1	TeicoplaninIBA 01/2022
1	ivacaftorIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	AcidsIBA 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	atabecestatIBA 01/2021
1	LigandsIBA 01/2021
1	Clozapine (Clozaril)FDA LinkGeneric 11/2020
1	Antipsychotic Agents (Antipsychotics)IBA 11/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	InterferonsIBA 01/2019
1	telaprevirIBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	Immunoglobulin G (IgG)IBA 12/2017
1	AntibodiesIBA 12/2017
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2017
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Lapatinib (GW572016)FDA Link 12/2016
1	Oxypurinol (Oxipurinol)IBA 12/2016
1	ximelagatran (Exanta)IBA 12/2016
1	lumiracoxib (prexige)IBA 12/2016
1	Reverse Transcriptase InhibitorsIBA 04/2014
1	NucleosidesIBA 04/2014
1	HLA-A31 antigenIBA 02/2014
1	HLA-DRB1*04 antigenIBA 02/2014
1	Human Serum Albumin FDA LinkGeneric 06/2013
1	Meropenem (Merrem)FDA LinkGeneric 06/2013
1	Aztreonam FDA LinkGeneric 06/2013
1	AlbuminsIBA 06/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2007
2	Drug Therapy (Chemotherapy) 07/2006 - 01/2004
1	Transplantation 08/2015